Another fantastic announcement highlighting Bisantrene's utility in the cancer space and it's potential of becoming the Robin to many of the industries Batmans.
The commercial possibilities are almost too distracting to comprehend.
RAC is obscenely undervalued, but you can sense the dam wall breaking as it breaks the shackles.
Good luck to all.
Ann: Bisantrene Highly Active in a Multiple Myeloma Mouse Model, page-8
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.015(1.28%) |
Mkt cap ! $201.5M | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.18 | $1.15 | $43.72K | 37.52K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4346 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.20 | 2188 | 1 |
View Market Depth
| Last trade - 16.10pm 14/07/2025 (20 minute delay) ? |
| RAC (ASX) Chart |